Torisel 25mg For Intravenous Drip Infusion Special Investigation - Survey On Long-Term Use

Next Previous
Trial Profile

Torisel 25mg For Intravenous Drip Infusion Special Investigation - Survey On Long-Term Use

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 07 Apr 2017

At a glance

  • Drugs Temsirolimus (Primary)
  • Indications Renal cell carcinoma
  • Focus Therapeutic Use
  • Sponsors Pfizer

    • Most Recent Events

    • 02 Apr 2017 Planned End Date changed from 1 Jul 2015 to 1 Jan 2018.
    • 02 Apr 2017 Planned primary completion date changed from 1 Jul 2015 to 1 Jan 2018.
    • 02 Apr 2017 Status changed from completed to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top